SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
992.00    44.00 (4.64%)
Bid:
972.00
Ask:
988.00
Spread: 16.00 (1.646%)
Market Cap: £271.52m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

AGM Trading Update

24 Feb 2025 07:00

RNS Number : 1756Y
Gooch & Housego PLC
24 February 2025
Β 

Β 

Β 

24 February 2025

Β 

Gooch & Housego PLC

("G&H" or the "Company" or the "Group")

Β 

AGM Trading Update

Β 

"Further order book growth underpins improving trading performance"

Β 

Β 

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components & systems, will hold its Annual General Meeting at 11.00 a.m. today at the Company's headquarters in Ilminster, Somerset.

Β 

Since the beginning of the financial year the Group's order book, including Phoenix Optical ("Phoenix") acquired at the end of October 2024, has increased to Β£126.4m (30 September 2024: Β£104.5m) supported by strong order intake for medical diagnostic instrument programmes and new orders for defence optics and subsea data networks. The Group is also responding to a growing number of requests from our A&D customers for high value quotations for periscope, sighting and countermeasure systems.

Β 

The Group continues to execute on its strategic objectives. Operational efficiency improvements are supporting the delivery of additional capacity from our own facilities and our contract manufacturing partners provide the Group with further flexibility to respond efficiently to changes in customer demand.

Β 

The integration of Phoenix is proceeding to plan. The business has increased the size of its order book since joining G&H reflecting increased confidence from its customers who are seeing Phoenix's ability to service additional levels of demand thanks to the operational support that the Group is able to provide. We continue to monitor the market for further bolt-on acquisition opportunities, in line with the Board's strict criteria, to accelerate our sustainable margin growth strategy.

Β 

The Group is closely monitoring the impact of new tariffs being implemented by the US administration and the retaliatory responses from the countries affected. Whilst the Group has low levels of direct procurement into its US facilities from China, Mexico and Canada there may be some indirect inflationary cost base impacts. We intend to pass those on to our customers in the form of price increases. We are also alert to any potential supply chain disruptions caused by China limiting the export of certain materials that are used in the manufacture of our products in response to the new tariff regime. Our supply chain and engineering teams are working to identify alternative sources for those materials.

Β 

As previously reported, the recovery in our semiconductor and industrial laser markets remains slow. We continue to expect those markets to recover in the second half of this calendar year and to contribute to the Group's trading in our fourth quarter. We are starting to see the level of customer orders improve in several of our Industrial sub-markets but the recovery is not yet broadly based.

Β 

In the first four months of the year the Group has reduced its working capital levels. As a result of the acquisition of the Phoenix business net bank debt at the end of January 2025 increased to Β£19.2m (30 September 2024: Β£16.0m) with Β£1.1m of the increase in the four-month period the result of currency exchange movements. Lease liabilities totalled Β£10.2m (30 September 2024: Β£9.9m).

Β 

Despite the macro-economic and geopolitical outlook continuing to remain uncertain, the Group's growing order book, strong pipeline of accretive new business opportunities and the success of our self-help measures provide good visibility and confidence for G&H going forward. Assuming the Group is successful in navigating the changing tariff landscape, the Board's expectations for FY2025 trading remain unchanged.

Β 

Charlie Peppiatt, Chief Executive Officer of Gooch and Housego, commented:

"I am pleased to see the increase in the Group's order book since the beginning of the year. It is clear the focus on delivering our strategic plan through improved customer experience, superior operational execution and value creating technology is starting to bear fruit. Whilst we are mindful of the uncertainty that new tariff regimes are introducing across several of our end markets, we remain positive that the Group will deliver a significantly improved financial performance in FY2025. The Group is strongly positioned in attractive growth markets and well placed to benefit as its industrial markets return to growth."

For further information please contact:

Β 

Charlie Peppiatt, Chief Executive Officer

Chris Jewell, Chief Financial OfficerΒ 

Gooch & Housego PLC

+44 (0) 1460 256440

Β 

Mark Court / Sophie Wills / Abigail Gilchrist

G&H@buchanan.uk.com

Burson Buchanan

+44 (0) 20 7466 5000

Β 

Christopher Baird / David Anderson

Investec Bank plc

+44 (0) 20 7597 5970

Β 

Β 

Notes to editors

Β 

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

Β 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

Β 

The person responsible for arranging the release of this announcement on behalf of the Company is Chris Jewell, Chief Financial Officer.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTPPUWUPUPAPUW
Date   Source Headline
3rd Jun 20267:00 amRNSDirectorate change
2nd Jun 20267:00 amRNSInterim Results
20th May 20267:00 amRNSNotice of Half Year Results
10th Apr 20262:25 pmRNSHolding(s) in Company
9th Apr 20267:00 amRNSHalf Year Trading Update
20th Mar 20263:16 pmRNSHolding(s) in Company
27th Feb 20262:23 pmRNSResult of AGM
27th Feb 20267:00 amRNSAGM Trading Update
2nd Feb 20267:00 amRNSChief Financial Officer appointment date
22nd Jan 20262:26 pmRNSHolding(s) in Company
13th Jan 20264:41 pmRNSHolding(s) in Company
12th Jan 20264:34 pmRNSPDMR notice
12th Jan 20263:30 pmRNSGrant of LTIP awards
9th Jan 20267:00 amRNSPDMR Notice and Issue of Equity
7th Jan 20267:00 amRNSPosting of Annual Report and Notice of AGM
12th Dec 20257:00 amRNSAppointment of Chief Financial Officer
2nd Dec 202511:36 amRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSResults for the year ended 30 September 2025
25th Nov 20257:00 amRNSNotification of Full Year Results
20th Nov 20252:14 pmRNSHolding(s) in Company
4th Nov 20257:07 amRNSDirectorate Update
8th Oct 20257:00 amRNSFurther Issue of Shares and TVR
7th Oct 20257:00 amRNSFull Year Trading Update
1st Oct 20252:15 pmRNSHolding(s) in Company
21st Jul 20257:00 amRNSChief Financial Officer Transition
15th Jul 20255:08 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSNotification of Major Holdings
23rd Jun 20252:30 pmRNSHolding(s) in Company - Replacement
20th Jun 202512:08 pmRNSHolding(s) in Company
18th Jun 20257:00 amRNSCompletion of Acquisition & Total Voting Rights
3rd Jun 20257:00 amRNSInterim Results
20th May 20257:00 amRNSNotification of Half Year Results
14th May 20257:00 amRNSAcquisition of Global Photonics
9th Apr 20252:16 pmRNSHolding(s) in Company
8th Apr 20257:00 amRNSHalf Year Trading Update
24th Feb 20252:19 pmRNSResult of AGM
24th Feb 20257:00 amRNSAGM Trading Update
7th Jan 20252:58 pmRNSGrant of LTIP Awards
6th Jan 202511:15 amRNSPosting of Annual Report and Notice of AGM
20th Dec 20243:15 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSResults for the year ended 30 September 2024
4th Nov 20247:00 amRNSNotification of Full Year Results
30th Oct 20247:00 amRNSAcquisition of Phoenix Optical
28th Oct 20242:35 pmRNSHolding(s) in Company
8th Oct 20247:00 amRNSFull Year Trading Update
26th Sep 202410:31 amRNSDirector/PDMR Shareholding
23rd Aug 202412:52 pmRNSNotification of Major Holdings
16th Aug 20245:46 pmRNSHolding(s) in Company
16th Aug 20244:49 pmRNSHolding(s) in Company
15th Aug 20244:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.